Dr. Elkin’s primary research interest is evaluating determinants of cancer screening, treatment and outcomes using population-based observational data analysis, decision analysis and patient surveys. Her current research focuses on the development of patient-centered tools to facilitate decisions about cancer screening. Funded studies include prospective evaluations of a web-based decision aid for women in their 40’s considering screening mammography and a similar tool for current and former smokers considering low-dose chest CT for lung cancer screening. She also conducts cost-effectiveness analyses of health and medical interventions, including a patient-directed program to increase screening mammography in survivors of Hodgkin lymphoma and a multi-faceted intervention to increase skin cancer screening in childhood cancer survivors. Dr. Elkin also advises a number of trainees and junior faculty members in studies of cancer treatment patterns, complications, survival and costs using the population-based SEER-Medicare dataset. Other research interests include studying the economic impact of cancer treatment on patients, their families and the health care system, and understanding and improving clinical decision-making processes from both patient and provider perspectives.
From September 2016 through August 2017, Dr. Elkin served as Congressional Fellow in the prestigious Robert Wood Johnson Health Policy Fellowship program. As part of this program, Dr. Elkin worked in the office of Senator Sheldon Whitehouse (D-RI), a member of the Senate Health, Education, Labor and Pensions Committee. In her role as a Health Policy Fellow, Dr. Elkin prepared reports and contributed to draft legislation on a wide range of federal health policy topics, including patient safety and hospital-acquired infections, primary care reimbursement, prescription drug prices, the Affordable Care Act, graduate medical education, and Medicaid fraud.